FEDERATED HERMES, INC. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$9,665
-35.1%
609
-22.8%
0.00%
Q2 2023$14,888
+35347.6%
789
+7072.7%
0.00%
Q1 2023$42
-6.7%
11
+22.2%
0.00%
Q4 2022$45
-95.5%
9
+80.0%
0.00%
Q3 2022$1,000
-50.0%
5
-87.5%
0.00%
Q2 2022$2,000
+100.0%
40
+1900.0%
0.00%
Q1 2022$1,0000.0%2
+100.0%
0.00%
Q4 2021$1,000
-99.9%
1
-100.0%
0.00%
-100.0%
Q2 2021$1,015,000
-76.7%
154,043
-71.4%
0.00%
-75.0%
Q1 2021$4,364,000
+145366.7%
538,755
+103109.8%
0.01%
Q4 2020$3,000
-92.5%
522
-95.4%
0.00%
Q3 2020$40,000
-25.9%
11,246
-3.0%
0.00%
Q2 2020$54,000
-93.6%
11,592
-95.3%
0.00%
-100.0%
Q1 2020$839,000
+27.7%
246,001
+91.1%
0.00%
+100.0%
Q4 2019$657,000
+32750.0%
128,706
+22965.6%
0.00%
Q3 2019$2,000
-99.6%
558
-99.0%
0.00%
-100.0%
Q2 2018$520,000
+139.6%
53,455
+158.9%
0.00%
+100.0%
Q1 2018$217,000
+97.3%
20,643
+19.9%
0.00%
Q4 2017$110,000
-80.4%
17,213
-76.5%
0.00%
-100.0%
Q3 2017$560,000
-42.9%
73,190
-47.0%
0.00%
-33.3%
Q2 2017$981,000
+890.9%
138,032
+441.2%
0.00%
Q1 2017$99,000
-55.2%
25,507
-76.4%
0.00%
-100.0%
Q4 2016$221,000
+29.2%
108,104
+69.6%
0.00%
Q3 2016$171,000
+17000.0%
63,751
+56820.5%
0.00%
Q2 2016$1,000
-98.0%
112
-97.7%
0.00%
Q3 2014$51,0004,8310.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders